These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2233326)

  • 1. Biochemical pharmacology of inflammatory liver injury in mice.
    Wendel A
    Methods Enzymol; 1990; 186():675-80. PubMed ID: 2233326
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice.
    Safayhi H; Mack T; Ammon HP
    Biochem Pharmacol; 1991 May; 41(10):1536-7. PubMed ID: 2018558
    [No Abstract]   [Full Text] [Related]  

  • 3. FK 506 modulates D-galactosamine-induced hepatitis in rats.
    Farghali H; Gasbarrini A; Borle AB; Nalesnik MA; Francavilla A; Fagiuoli S; Starzl TE; Van Thiel DH
    Transplant Proc; 1991 Dec; 23(6):2809-11. PubMed ID: 1721285
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G
    Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
    Nagakawa J; Hishinuma I; Miyamoto K; Hirota K; Abe S; Yamanaka T; Katayama K; Yamatsu I
    J Pharmacol Exp Ther; 1992 Jul; 262(1):145-50. PubMed ID: 1625194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression.
    Okamoto T; Kanda T
    Int J Mol Med; 1999 Aug; 4(2):149-52. PubMed ID: 10402481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orotate prevents galactosamine hepatitis.
    Keppler D; Rudigier J; Reutter W; Lesch R; Decker K
    Hoppe Seylers Z Physiol Chem; 1970 Jan; 351(1):102-4. PubMed ID: 5411959
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Tiegs G; Wolter M; Wendel A
    Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of protective action of bicyclol against CCl-induced liver injury in mice.
    Liu GT; Li Y; Wei HL; Zhang H; Xu JY; Yu LH
    Liver Int; 2005 Aug; 25(4):872-9. PubMed ID: 15998439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone protects endotoxin-induced liver injury after hepatic ischemia in rats.
    Kaibori M; Yanagida H; Uchida Y; Yokoigawa N; Kwon AH; Okumura T; Kamiyama Y
    Transplant Proc; 2004 Sep; 36(7):1973-4. PubMed ID: 15518715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene-mediated liver injury.
    Tiegs G; Wendel A
    Biochem Pharmacol; 1988 Jul; 37(13):2569-73. PubMed ID: 2839197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity of acetaldehyde in rats.
    Strubelt O; Younes M; Urch T; Breining H; Pentz R
    Toxicol Lett; 1987 Nov; 39(1):77-84. PubMed ID: 3672558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin-converting enzyme inhibitor captopril rescues mice from endotoxin-induced lethal hepatitis.
    Ge P; Jiang R; Yao X; Li J; Dai J; Zhang L; Ye B
    Innate Immun; 2017 Feb; 23(2):128-135. PubMed ID: 27879415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by sinomenine against endotoxin-induced fulminant hepatitis in galactosamine-sensitized mice.
    Kondo Y; Takano F; Yoshida K; Hojo H
    Biochem Pharmacol; 1994 Aug; 48(5):1050-2. PubMed ID: 8093093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum transaminases, SDH and liver morphology after treatment with trypanocidal diamidines in mice.
    Steinmann U; Sippel H; Pesch HJ; Estler CJ
    Toxicol Lett; 1985 May; 25(2):161-5. PubMed ID: 4002247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice.
    Amat N; Upur H; Blazeković B
    J Ethnopharmacol; 2010 Sep; 131(2):478-84. PubMed ID: 20637853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.
    Ben-Ari Z; Zilbermints V; Pappo O; Avlas O; Sharon E; Greif F; Cheporko Y; Ravid A; Shapiro R; Hochhauser E
    Transplantation; 2011 Jul; 92(1):18-24. PubMed ID: 21516061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
    Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
    Park EJ; Nan JX; Zhao YZ; Lee SH; Kim YH; Nam JB; Lee JJ; Sohn DH
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):298-304. PubMed ID: 15228502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.